TSE:FRX - Adherex Technologies Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
C$14.00 -0.90 (-6.04 %)
(As of 05/20/2018 03:46 PM ET)
Previous CloseC$14.00
Today's RangeC$14.00 - C$14.90
52-Week RangeC$4.61 - C$18.86
Volume1,000 shs
Average Volume2,754 shs
Market CapitalizationC$218.17 million
P/E RatioN/A
Dividend YieldN/A
Beta0.5

About Adherex Technologies (TSE:FRX)

Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product candidate is the Sodium Thiosulfate, which has completed the Phase III clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was founded in 1996 and is based in Research Triangle Park, North Carolina.

Receive FRX News and Ratings via Email

Sign-up to receive the latest news and ratings for FRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
SymbolTSE:FRX
CUSIPN/A
Phone+1-919-6364530

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on Equity-101.78%
Return on Assets-93.65%

Miscellaneous

EmployeesN/A
Outstanding Shares18,465,000

Adherex Technologies (TSE:FRX) Frequently Asked Questions

What is Adherex Technologies' stock symbol?

Adherex Technologies trades on the Toronto Stock Exchange (TSX) under the ticker symbol "FRX."

How were Adherex Technologies' earnings last quarter?

Adherex Technologies Inc (TSE:FRX) issued its earnings results on Monday, March, 26th. The biopharmaceutical company reported ($0.19) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.17) by $0.02. View Adherex Technologies' Earnings History.

When is Adherex Technologies' next earnings date?

Adherex Technologies is scheduled to release their next quarterly earnings announcement on Friday, August, 10th 2018. View Earnings Estimates for Adherex Technologies.

What price target have analysts set for FRX?

3 Wall Street analysts have issued 12-month target prices for Adherex Technologies' stock. Their predictions range from C$22.00 to C$22.00. On average, they expect Adherex Technologies' share price to reach C$22.00 in the next twelve months. View Analyst Ratings for Adherex Technologies.

Who are some of Adherex Technologies' key competitors?

Who are Adherex Technologies' key executives?

Adherex Technologies' management team includes the folowing people:
  • Mr. Rostislav Raykov, Pres, CEO & Director (Age 42)
  • Mr. Robert C. Andrade, Chief Financial Officer (Age 43)
  • Mr. Mark Gowland, Controller
  • Mr. Lei Fang, Pres of Pharstat Inc
  • Ms. Anne McKay, Regulatory Consultant (Age 64)

Has Adherex Technologies been receiving favorable news coverage?

News articles about FRX stock have been trending somewhat positive recently, according to Accern. The research firm identifies negative and positive media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Adherex Technologies earned a media sentiment score of 0.18 on Accern's scale. They also gave news coverage about the biopharmaceutical company an impact score of 45.27 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near future.

How do I buy shares of Adherex Technologies?

Shares of FRX and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Adherex Technologies' stock price today?

One share of FRX stock can currently be purchased for approximately C$14.00.

How big of a company is Adherex Technologies?

Adherex Technologies has a market capitalization of C$218.17 million.

How can I contact Adherex Technologies?

Adherex Technologies' mailing address is 68 Tw Alexander Dr PO Box 13628, DURHAM, NC 27709-3628, United States. The biopharmaceutical company can be reached via phone at +1-919-6364530.


MarketBeat Community Rating for Adherex Technologies (FRX)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  50 (Vote Outperform)
Underperform Votes:  54 (Vote Underperform)
Total Votes:  104
MarketBeat's community ratings are surveys of what our community members think about Adherex Technologies and other stocks. Vote "Outperform" if you believe FRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FRX will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Adherex Technologies (TSE:FRX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Adherex Technologies in the last 12 months. Their average twelve-month price target is C$22.00, suggesting that the stock has a possible upside of 57.14%. The high price target for FRX is C$22.00 and the low price target for FRX is C$22.00. There are currently 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyN/A
Consensus Rating Score: 3.003.003.00N/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: C$22.00C$22.00C$22.00N/A
Price Target Upside: 57.14% upside81.67% upside74.19% upsideN/A

Adherex Technologies (TSE:FRX) Consensus Price Target History

Price Target History for Adherex Technologies (TSE:FRX)

Adherex Technologies (TSE:FRX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
3/12/2018WedbushReiterated RatingOutperformView Rating Details
2/20/2018HC WainwrightReiterated RatingBuyView Rating Details
11/29/2017LaidlawInitiated CoverageBuyC$22.00View Rating Details
(Data available from 5/20/2016 forward)

Earnings

Adherex Technologies (TSE:FRX) Earnings History and Estimates Chart

Earnings by Quarter for Adherex Technologies (TSE:FRX)

Adherex Technologies (TSE:FRX) Earnings Estimates

2018 EPS Consensus Estimate: ($0.61)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.19)($0.19)($0.19)
Q2 20181($0.13)($0.13)($0.13)
Q3 20181($0.14)($0.14)($0.14)
Q4 20181($0.15)($0.15)($0.15)

Adherex Technologies (TSE FRX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/10/2018        
3/26/2018Q4 2017C($0.17)C($0.19)ViewN/AView Earnings Details
11/13/2017Q3 2017C($0.19)ViewN/AView Earnings Details
8/11/2017Q2 2017C($0.15)ViewN/AView Earnings Details
5/12/2017Q1 2017C($0.08)ViewN/AView Earnings Details
3/30/2017Q4 2016C($0.11)ViewN/AView Earnings Details
11/14/2016Q3 2016C($0.05)ViewN/AView Earnings Details
8/12/2016Q2 2016C($0.08)ViewN/AView Earnings Details
5/12/2016Q1 2016C($0.05)ViewN/AView Earnings Details
3/28/2016Q4 2015C($0.06)ViewN/AView Earnings Details
11/12/2015Q3 2015C($0.01)ViewN/AView Earnings Details
8/11/2015Q2 15C($0.02)ViewN/AView Earnings Details
5/15/2015Q1 2015C($0.05)ViewN/AView Earnings Details
4/1/2015Q4 2014C$0.18ViewN/AView Earnings Details
11/13/2014Q3 2014C$0.03ViewN/AView Earnings Details
8/11/2014Q2 2014C($0.09)ViewN/AView Earnings Details
5/15/2014Q1 2014C($0.06)ViewN/AView Earnings Details
3/31/2014Q4 2013C($0.06)ViewN/AView Earnings Details
11/15/2013Q3 2013C($0.21)ViewN/AView Earnings Details
8/9/2013Q2 2013C$0.81ViewN/AView Earnings Details
5/13/2013Q1 2013C($0.06)ViewN/AView Earnings Details
4/1/2013Q4 2012C($0.12)ViewN/AView Earnings Details
11/13/2012Q3 2012C($0.09)ViewN/AView Earnings Details
8/13/2012Q2 2012C($0.06)ViewN/AView Earnings Details
5/11/2012Q1 2012C$0.33ViewN/AView Earnings Details
3/27/2012Q4 2011C$0.42ViewN/AView Earnings Details
11/14/2011Q3 2011C($0.52)ViewN/AView Earnings Details
5/13/2011Q1 2011C$0.54ViewN/AView Earnings Details
3/31/2011Q4 2010C($1.03)ViewN/AView Earnings Details
11/15/2010Q3 2010C$0.54ViewN/AView Earnings Details
3/30/2010Q4 2009C$0.11ViewN/AView Earnings Details
8/14/2009Q2 2009C($0.59)ViewN/AView Earnings Details
5/14/2009Q1 2009C($1.13)ViewN/AView Earnings Details
3/30/2009Q4 2008C($1.35)ViewN/AView Earnings Details
11/12/2008Q3 2008C($1.67)ViewN/AView Earnings Details
8/13/2008Q2 2008C($1.62)ViewN/AView Earnings Details
5/13/2008Q1 2008C($1.62)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Adherex Technologies (TSE:FRX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Adherex Technologies (TSE FRX) Insider Trading and Institutional Ownership History

Insider Trading History for Adherex Technologies (TSE:FRX)

Adherex Technologies (TSE FRX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/12/2017S.P.A. EssetifinInsiderBuy294,115C$8.50C$2,499,977.50
(Data available from 1/1/2013 forward)

Headlines

Adherex Technologies (TSE FRX) News Headlines

Source:
DateHeadline
Wedbush Weighs in on Adherex Technologies Incs Q2 2018 Earnings (FRX)Wedbush Weighs in on Adherex Technologies Inc's Q2 2018 Earnings (FRX)
www.americanbankingnews.com - May 17 at 5:59 AM
Wedbush Comments on Adherex Technologies Incs FY2022 Earnings (FRX)Wedbush Comments on Adherex Technologies Inc's FY2022 Earnings (FRX)
www.americanbankingnews.com - May 16 at 8:20 AM
Brokers Issue Forecasts for Adherex Technologies Incs Q1 2018 Earnings (FRX)Brokers Issue Forecasts for Adherex Technologies Inc's Q1 2018 Earnings (FRX)
www.americanbankingnews.com - March 30 at 6:52 AM
FY2020 Earnings Forecast for Adherex Technologies Inc Issued By Wedbush (FRX)FY2020 Earnings Forecast for Adherex Technologies Inc Issued By Wedbush (FRX)
www.americanbankingnews.com - March 29 at 8:46 AM
Fennec Pharmaceuticals (FRX) Earns "Outperform" Rating from WedbushFennec Pharmaceuticals (FRX) Earns "Outperform" Rating from Wedbush
www.americanbankingnews.com - March 15 at 10:42 AM
Fennec Pharmaceuticals Inc (FRX) to Post FY2017 Earnings of ($0.56) Per Share, Wedbush ForecastsFennec Pharmaceuticals Inc (FRX) to Post FY2017 Earnings of ($0.56) Per Share, Wedbush Forecasts
www.americanbankingnews.com - March 15 at 6:31 AM
Fennec Pharmaceuticals (FRX) Stock Rating Reaffirmed by HC WainwrightFennec Pharmaceuticals (FRX) Stock Rating Reaffirmed by HC Wainwright
www.americanbankingnews.com - February 23 at 11:58 PM
Fennec Announces Closing of Public OfferingFennec Announces Closing of Public Offering
finance.yahoo.com - December 21 at 5:24 PM
Fennec Pharmaceuticals Inc. (FRX) Insider S.P.A. Essetifin Buys 294,115 SharesFennec Pharmaceuticals Inc. (FRX) Insider S.P.A. Essetifin Buys 294,115 Shares
www.americanbankingnews.com - December 13 at 2:34 PM
Fennec Announces Pricing of Public Offering - GlobeNewswire (press release)Fennec Announces Pricing of Public Offering - GlobeNewswire (press release)
globenewswire.com - December 10 at 9:23 AM
Fennec Announces Pricing of Public OfferingFennec Announces Pricing of Public Offering
finance.yahoo.com - December 8 at 9:23 AM
Laidlaw Initiates Coverage on Fennec Pharmaceuticals (FRX)Laidlaw Initiates Coverage on Fennec Pharmaceuticals (FRX)
www.americanbankingnews.com - November 29 at 10:47 AM
Fennec Pharma Q3 Net Loss Widens On Higher Expenses - Quick Facts - NasdaqFennec Pharma Q3 Net Loss Widens On Higher Expenses - Quick Facts - Nasdaq
www.nasdaq.com - November 14 at 5:08 AM
Fennec Pharma Q3 Net Loss Widens On Higher Expenses - Quick FactsFennec Pharma Q3 Net Loss Widens On Higher Expenses - Quick Facts
www.rttnews.com - November 13 at 9:57 AM
Fennec Provides Business Update And Reports Third Quarter 2017 ResultsFennec Provides Business Update And Reports Third Quarter 2017 Results
finance.yahoo.com - November 13 at 9:57 AM
BRIEF-Fennec pharmaceuticals files for stock shelf of up to $90 mlnBRIEF-Fennec pharmaceuticals files for stock shelf of up to $90 mln
www.reuters.com - October 25 at 12:21 AM
ANIK Expands Horizons, FENC Hits Study Goals, IMDZ Abuzz, One More For Opdivo - NasdaqANIK Expands Horizons, FENC Hits Study Goals, IMDZ Abuzz, One More For Opdivo - Nasdaq
www.nasdaq.com - October 18 at 5:34 AM
Fennec Announces Positive Results From Phase 3 SIOPEL 6 Study on PEDMARK™ (sodium thiosulfate) Presented at ... - GlobeNewswire (press release)Fennec Announces Positive Results From Phase 3 SIOPEL 6 Study on PEDMARK™ (sodium thiosulfate) Presented at ... - GlobeNewswire (press release)
globenewswire.com - October 18 at 5:34 AM
Fennec Phase 3 SIOPEL 6 Study On PEDMARK Meets Primary Goal - Quick FactsFennec Phase 3 SIOPEL 6 Study On PEDMARK Meets Primary Goal - Quick Facts
www.nasdaq.com - October 16 at 7:14 PM
Can Fennec Pharmaceuticals Inc (FENC) Improve Your Portfolio Returns?Can Fennec Pharmaceuticals Inc (FENC) Improve Your Portfolio Returns?
finance.yahoo.com - October 16 at 7:14 PM
New Technology Could Help Detect The Leading Cause Of Strokes - Baystreet.caNew Technology Could Help Detect The Leading Cause Of Strokes - Baystreet.ca
www.baystreet.ca - September 15 at 12:30 AM
Avigilon at new 52-Week High on New Contract - Baystreet.caAvigilon at new 52-Week High on New Contract - Baystreet.ca
www.baystreet.ca - September 15 at 12:30 AM
Keep Close Watch On ALDX Today, ABBV Just Hit Another High, Fennec Uplisted - NasdaqKeep Close Watch On ALDX Today, ABBV Just Hit Another High, Fennec Uplisted - Nasdaq
www.nasdaq.com - September 15 at 12:30 AM
Avigilon at new 52-Week High on New ContractAvigilon at new 52-Week High on New Contract
www.baystreet.ca - September 14 at 7:29 PM
IIROC Trading Halt - FRXIIROC Trading Halt - FRX
finance.yahoo.com - September 13 at 8:17 PM
Fennec Announces Preliminary Results of SIOPEL 6 Study on PEDMARK™ (sodium thiosulfate) to be Presented at the 49TH Congress of the International Society of Pediatric Oncology (SIOP) 2017 MeetingFennec Announces Preliminary Results of SIOPEL 6 Study on PEDMARK™ (sodium thiosulfate) to be Presented at the 49TH Congress of the International Society of Pediatric Oncology (SIOP) 2017 Meeting
finance.yahoo.com - September 13 at 8:17 PM
IIROC Trade Resumption - FRXIIROC Trade Resumption - FRX
finance.yahoo.com - September 13 at 8:17 PM
Fennec Pharmaceuticals Announces Listing on the Nasdaq Capital MarketFennec Pharmaceuticals Announces Listing on the Nasdaq Capital Market
finance.yahoo.com - September 11 at 7:23 PM
Fennec Provides Corporate Update and Announces Second Quarter 2017 ResultsFennec Provides Corporate Update and Announces Second Quarter 2017 Results
finance.yahoo.com - August 11 at 7:17 PM
Air Canada at 52-Week High - Baystreet.caAir Canada at 52-Week High - Baystreet.ca
www.baystreet.ca - July 9 at 12:22 AM
Mogo, TransAlta at 52-Week Highs - Baystreet.caMogo, TransAlta at 52-Week Highs - Baystreet.ca
www.baystreet.ca - June 30 at 7:06 PM
Shaw out with Q3 Numbers, Hits 52-Week Highs - Baystreet.caShaw out with Q3 Numbers, Hits 52-Week Highs - Baystreet.ca
www.baystreet.ca - June 28 at 11:29 PM
CNR, Star Yield at 52-Week HighsCNR, Star Yield at 52-Week Highs
www.baystreet.ca - June 9 at 5:44 PM
BRIEF-Fennec reports Q1 loss per share $0.06BRIEF-Fennec reports Q1 loss per share $0.06
www.reuters.com - May 12 at 10:55 PM
Jazz Pharma To Play Its Acquisition Riffs Again: All Notes Point To 2 Otology CompaniesJazz Pharma To Play Its Acquisition Riffs Again: All Notes Point To 2 Otology Companies
seekingalpha.com - April 7 at 5:12 PM
EARNINGS SUMMARY: Details of Fennec Pharmaceuticals Inc. Q3 Earnings ReportEARNINGS SUMMARY: Details of Fennec Pharmaceuticals Inc. Q3 Earnings Report
www.rttnews.com - November 14 at 9:03 AM

SEC Filings

Adherex Technologies (TSE:FRX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Adherex Technologies (TSE FRX) Stock Chart for Sunday, May, 20, 2018

Loading chart…

This page was last updated on 5/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.